The role of patiromer: Comparing OPAL-HK data with untreated real-world patients in the United Kingdom—A retrospective, propensity-matched analysis
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference11 articles.
1. Prevalence and factors associated with hyperkalaemia in predialysis patients followed in a low-clearance clinic;PA Sarafidis;Clin J Am Soc Nephrol,2012
2. Renoprotection of optimal antiproteinuric doses (ROAD) study: a randomised controlled study of benazepril and losartan in chronic renal insufficiency;FF Hou;J Am Soc Nephrol,2007
3. Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease;KDIGO;Kidney Int,2013
4. Revisting RAAS-blockade in CKD with newer potassium binding drugs;PI Georgianos;Kidney Int,2018
5. Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors;MR Weir;N Engl J Med,2015
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Proteomic signature associated with chronic kidney disease (CKD) progression identified by data-independent acquisition mass spectrometry;Clinical Proteomics;2023-04-20
2. Renin–angiotensin–aldosterone pathway modulators in chronic kidney disease: A comparative review;Frontiers in Pharmacology;2023-02-13
3. Maintaining Renin-Angiotensin-Aldosterone System Inhibitor Treatment with Patiromer in Hyperkalaemic Chronic Kidney Disease Patients: Comparison of a Propensity-Matched Real-World Population with AMETHYST-DN;American Journal of Nephrology;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3